Dupilumab in Moderate-To-Severe Atopic Dermatitis With or Without Comorbid Food Allergy: Pooled Analysis of 2 Randomized Phase 3 Trials (LIBERTY AD SOLO 1 & 2)
Journal of Allergy and Clinical Immunology - United States
doi 10.1016/j.jaci.2017.12.418
Full Text
Open PDFAbstract
Available in full text
Date
February 1, 2018
Authors
Publisher
Elsevier BV